Sustiva Related Clinical Trials
Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients [Active, not recruiting]
Study of Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. [Active, not recruiting]
TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [Completed]
Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects [Active, not recruiting]
A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects [Completed]
A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects [Completed]
Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily [Completed]
Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children [Active, not recruiting]
Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine [Active, not recruiting]
A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors [Completed]
Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects [Completed]
Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV [Completed]
The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz [Completed]
Drug Interaction - Oral Contraceptive [Completed]
Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment [Active, not recruiting]
FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment [Completed]
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection [Available]
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada [Available]
Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage [Active, not recruiting]
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults [Completed]
Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment [Recruiting]
Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients [Recruiting]
Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz [Completed]
Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment [Completed]
Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Active, not recruiting]
The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [Completed]
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment [Active, not recruiting]
Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics [Recruiting]
Combination of Efavirenz and Truvada - COMET Study [Completed]
A Study of Indinavir Taken With or Without DMP 266 [Completed]
TMC 125 Blood Levels Study [Completed]
A Study of Efavirenz in Combination With Stavudine and Didanosine [Completed]
A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Completed]
Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects [Active, not recruiting]
Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [Completed]
Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients [Completed]
A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients [Completed]
A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects [Withdrawn]
Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs [Active, not recruiting]
The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors [Completed]
Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-Infected Patients With Tuberculosis [Not yet recruiting]
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [Completed]
ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past [Completed]
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs [Active, not recruiting]
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs [Active, not recruiting]
The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs [Completed]
Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir [Completed]
Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children [Recruiting]
Drug Interactions Among Anti-HIV Agents [Completed]
A Comparison of Two Drug Combinations Used in HIV-Infected Patients Who Never Have Taken Anti-HIV Drugs [Completed]
Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [Completed]
A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults [Completed]
Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients [Completed]
Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen [Completed]
A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients [Completed]
A Study to Compare Two Anti-HIV Drug Combinations [Completed]
A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication [Recruiting]
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-Based HAART in Advanced HIV Disease [Recruiting]
Effect of Genetics on Metabolism of Efavirenz [Recruiting]
A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen [Completed]
Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China [Completed]
Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg [Recruiting]
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults [Active, not recruiting]
Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART [Completed]
A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients [Completed]
Efavirenz-Based Versus Nevirapine-Based Antiretroviral Therapy Among HIV-Infected Patients Receiving Rifampin [Recruiting]
Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults [Completed]
Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz. [Terminated]
A Study to Evaluate the Safety and Antiretroviral Activity of MK0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA(TM) [Active, not recruiting]
Efavirenz to Nevirapine Switch and LDL-Dyslipidemia [Terminated]
Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB co-Infected Patients (ANRS 12146 CARINEMO) [Recruiting]
Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection [Not yet recruiting]
Safety and Effectiveness of a Combination Anti-HIV Drug Treatment [Completed]
Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations [Recruiting]
Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal [Not yet recruiting]
TMC278-TiDP6-C209: A Clinical Trial in Treatment naïve HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine. [Recruiting]
TMC278-TiDP6-C215: A Clinical Trial in Treatment naïve HIV-Subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors [Recruiting]
TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers. [Recruiting]
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT [Recruiting]
Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) [Completed]
Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients [No longer recruiting]
Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults [Recruiting]
Drug Interaction Study Between Antimalarial and Anti-HIV Medications [Recruiting]
HIV Antiretroviral Drugs and Metabolism [Recruiting]
A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients [Completed]
2NN & CHARM Long-Term Follow-up Study [Completed]
A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy [No longer recruiting]
Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis [Terminated]
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs [Completed]
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients [Completed]
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis [Recruiting]
DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy [Completed]
DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy [Completed]
Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients [Completed]
Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) [Completed]
Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients [Completed]
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Suspended]
Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women [Completed]
A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible [Completed]
The Adult Antiretroviral Treatment and Resistance Study (Tshepo) [No longer recruiting]
ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens [Not yet recruiting]
|
